People

Alex Bennett
Alex S. Bennett, PhD, MS
NYU School of Global Public Health - Research Associate Professor
NYU School of Global Public Health - Director, Opioid Overdose Prevention Program
Email: asb19@nyu.edu
Education
PhD/MS, History and Policy, Carnegie Mellon University
MPA, Public Policy Research and Analysis, University of Pittsburgh
BA/MA, History, University of Florida
Research Interests
Overdose prevention, Naloxone, Veterans health, Mixed-methods research, Opioids, Drug use, HIV/HCV prevention, Community-engaged research
BIO
Alex Bennett specializes in ethnographic, historical and mixed-methods research to address drug overdose, infectious disease and other drug-related harm among a broad cross-section of at-risk populations including military veterans, people who use and/or inject drugs, and those managing various forms of biopsychosocial pain. He has been involved in substance use and overdose prevention both in academic and community settings conducting research, needs assessment, program development, service delivery, and evaluation work.  In his research, Dr. Bennett has focused on a wide range of psychoactives in both historical and contemporary contexts. Over the past decade, he has been working with military veterans, as partners and community health outreach specialists, to develop harm reduction programs tailored to veterans who use opioids to prevent overdose and blood-borne viral infection while simultaneously helping them access low-threshold healthcare and supportive services.
Projects
Principal Investigator, Evaluation of a Community-Based Education, Navigation, and Support (CENS) Intervention to Reduce Opioid-Related Harms Among Military Veterans. Active
Principal Investigator, Expanding Opioid Overdose Prevention Program Capacity in New York City. Active
Principal Investigator, Overdose Risk Management and Compensation in the Era of Naloxone. Active
Principal Investigator, Opioid Misuse and Overdose Risk Patterns Among Recent Veterans. Completed
Principal Investigator, Technology to Increase Naloxone Uptake Among Opioid Users Who Initially Decline. Completed
Publications

Recent

Russell E, Hawk M, Neale J, Bennett A, Davis C, Hill LG, Winograd R, Kestner L, Lieberman A, Bell A, Santamour T, Murray S, Schneider KE, Walley AY, Jones TS (2024).
A call for compassionate opioid overdose response
International Journal of Drug Policy, 133, 104587. doi: 10.1016/j.drugpo.2024.104587.

Martin SI, Bennett AS, Elliott L, Gorgens KA (2024).
Overdose risk and brain injury (traumatic brain injury/acquired brain injury), a commentary
Substance Use and Misuse, 59 (11), 1656-1659. doi: 10.1080/10826084.2024.2359722.

Bather JR, Han L, Bennett AS, Elliott L, Goodman MS (2024).
Detecting univariate, bivariate, and overall effects of drug mixtures using Bayesian kernel machine regression
American Journal of Drug and Alcohol Abuse [Epuib 2024 Jul 23]. doi: 10.1080/00952990.2024.2380463.

Roth AM, Ward KM, Hensel DJ, Elliott L, Bennett AS (2024).
Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic
PLoS One, 19 (7), e0307151. doi: 10.1371/journal.pone.0307151. PMCID: PMC11257247.

Aronson ID, Ardouin-Guerrier MA, Baus JE, Bennett AS (2024).
Barriers to, and facilitators of, checking drugs for adulterants in the era of fentanyl and xylazine: Qualitative study
JMIR Formative Research, 8, e56755. doi: 10.2196/56755. PMCID: PMC11255526.


Notable

Bennett AS, Bell A, Tomedi L, Hulsey EG, Kral AH (2011).
Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania
Journal of Urban Health, 88 (6), 1020-1030. doi: 10.1007/s11524-011-9600-7. PMCID: PMC3232410.

Dr. Bennett's Research Gate Profile